Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Janel Corporation is a diversified holding company that operates a significant Life Sciences segment alongside its global logistics business. The company's life sciences portfolio includes specialized subsidiaries such as Antibodies Incorporated, Aves Labs, PhosphoSolutions, and ImmunoChemistry Technologies. These entities are dedicated to providing high-quality antibodies, reagents, and diagnostic tools to the global biomedical research community. Janel focuses on acquiring established, profitable businesses in the life science tools sector and supporting their long-term growth. Its products support research in critical areas such as neuroscience, immunology, and cell signaling. By integrating these niche providers, Janel serves as a comprehensive resource for researchers in both academia and the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Janel Corporation.